• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天冬酰胺370和谷氨酰胺235参与酸性β-葡萄糖苷酶的催化作用:该酶在戈谢病中缺乏。

Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher disease.

作者信息

Liou Benjamin, Grabowski Gregory A

机构信息

The A. Graeme Mitchell Chair in Human Genetics, Division and Program in Human Genetics, Children's Hospital Medical Center, 3333 Burnet Avenue, ML 4006, Cincinnati, OH 45229-3039, USA.

出版信息

Mol Genet Metab. 2009 May;97(1):65-74. doi: 10.1016/j.ymgme.2009.01.006. Epub 2009 Feb 13.

DOI:10.1016/j.ymgme.2009.01.006
PMID:19217815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2699545/
Abstract

The hydrolysis of glucosylceramide by acid beta-glucosidase proceeds via a two-step, double displacement mechanism that includes cleavage of the O-beta-glucosidic bond, enzyme-glucosylation and, then, enzyme-deglucosylation. Two residues that may impact this cycle are N370 and E235. The N370S mutant enzyme is very common in Gaucher disease type 1 patients. Homology and crystal data predictions suggested that E235 is the acid/base catalyst in the hydrolytic reaction. Here, the roles of N370 and E235 in hydrolysis were explored using mutant proteins with selected amino acid substitutions. Heterologously expressed enzymes were characterized using inhibitors, activators, and alternative substrates to gain insight into the effects on the glucosylation (single turnover) and deglucosylation (transglucosylation) steps in catalysis. Specific substitutions at N370 selectively altered only the glucosylation step whereas N370S altered this and the deglucosylation steps. To provide functional data to support E235 as the acid/base catalyst, progress curves with poor substrates with more acidic leaving groups were used in the presence and absence of azide as an exogenous nucleophile. The restoration of E235G activity to nearly wild-type levels was achieved using azide with 2,4-dinitrophenyl-beta-glucoside as substrate. The loss of the acidic arm of the pH optimum activity curve of E235G provided additional functional support for E235 as the acid/base in catalysis. This study provides insight into the function of these residues in acid beta-glucosidase active site function.

摘要

酸性β-葡萄糖苷酶对葡萄糖神经酰胺的水解通过两步双取代机制进行,该机制包括O-β-糖苷键的断裂、酶的糖基化,然后是酶的去糖基化。可能影响这一循环的两个残基是N370和E235。N370S突变酶在1型戈谢病患者中非常常见。同源性和晶体数据预测表明E235是水解反应中的酸碱催化剂。在此,使用具有选定氨基酸取代的突变蛋白探索了N370和E235在水解中的作用。使用抑制剂、激活剂和替代底物对异源表达的酶进行表征,以深入了解对催化过程中糖基化(单次周转)和去糖基化(转糖基化)步骤的影响。N370处的特定取代仅选择性地改变了糖基化步骤,而N370S则改变了这一步骤和去糖基化步骤。为了提供功能数据以支持E235作为酸碱催化剂,在有和没有叠氮化物作为外源亲核试剂的情况下,使用了具有更多酸性离去基团的不良底物的进程曲线。使用叠氮化物和2,4-二硝基苯基-β-葡萄糖苷作为底物,E235G的活性恢复到了接近野生型水平。E235G的pH最佳活性曲线酸性臂的丧失为E235作为催化中的酸碱提供了额外的功能支持。这项研究深入了解了这些残基在酸性β-葡萄糖苷酶活性位点功能中的作用。

相似文献

1
Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher disease.天冬酰胺370和谷氨酰胺235参与酸性β-葡萄糖苷酶的催化作用:该酶在戈谢病中缺乏。
Mol Genet Metab. 2009 May;97(1):65-74. doi: 10.1016/j.ymgme.2009.01.006. Epub 2009 Feb 13.
2
Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.使用激活剂和抑制剂来定义正常和戈谢病溶酶体β-葡萄糖苷酶活性位点的特性。
Enzyme. 1985;33(2):109-19. doi: 10.1159/000469416.
3
Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression.通过定点诱变和异源表达分析人酸性β-葡萄糖苷酶
J Biol Chem. 1994 Jan 21;269(3):2283-91.
4
Mechanism of the family 1 beta-glucosidase from Streptomyces sp: catalytic residues and kinetic studies.链霉菌属1型β-葡萄糖苷酶的作用机制:催化残基与动力学研究
Biochemistry. 2001 May 22;40(20):5975-82. doi: 10.1021/bi002947j.
5
The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.亚氨基糖异麦角甾苷通过多种机制提高戈谢病成纤维细胞中N370S突变型酸性β-葡萄糖苷酶的活性。
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13813-8. doi: 10.1073/pnas.0605928103. Epub 2006 Aug 31.
6
Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.通过定点诱变分析人酸性β-葡萄糖苷酶的催化活性和抑制剂结合。确定对催化至关重要的残基,并为两种1型阿什肯纳兹犹太戈谢病突变的因果关系提供证据。
J Biol Chem. 1990 Apr 25;265(12):6827-35.
7
X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.戈谢病中缺陷酶——人酸性β-葡萄糖苷酶的X射线结构。
EMBO Rep. 2003 Jul;4(7):704-9. doi: 10.1038/sj.embor.embor873.
8
X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.N370S 突变型人酸性β-葡萄糖苷酶的 X 射线和生化分析。
J Biol Chem. 2011 Jan 7;286(1):299-308. doi: 10.1074/jbc.M110.150433. Epub 2010 Oct 27.
9
Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.胆固醇的糖化作用是由β-葡萄糖苷酶 1 的转葡糖基化反应催化的。
Biochem Biophys Res Commun. 2013 Nov 29;441(4):838-43. doi: 10.1016/j.bbrc.2013.10.145. Epub 2013 Nov 6.
10
Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.影响从对照受试者和1型戈谢病患者脾脏中纯化的葡萄糖脑苷脂酶活性的条件。
Biochim Biophys Acta. 1990 Oct 18;1041(1):55-63. doi: 10.1016/0167-4838(90)90122-v.

引用本文的文献

1
Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.在小鼠中同时存在酸性β-葡萄糖苷酶突变和 Saposin C 缺乏会导致 Gba1 突变依赖性和组织特异性疾病表型。
Sci Rep. 2019 Apr 3;9(1):5571. doi: 10.1038/s41598-019-41914-7.
2
Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant.药理学伴侣促进重组 N370S 突变β-葡糖苷脑苷脂酶在植物细胞中的 ER 后转运:N370S 是一种折叠突变体的证据。
Mol Genet Metab. 2012 Jul;106(3):323-9. doi: 10.1016/j.ymgme.2012.04.018. Epub 2012 Apr 26.
3
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.溶酶体贮积症诊断中的生物标志物:蛋白质、脂质和抑制物。
J Inherit Metab Dis. 2011 Jun;34(3):605-19. doi: 10.1007/s10545-011-9308-6. Epub 2011 Mar 29.
4
Ultrasensitive in situ visualization of active glucocerebrosidase molecules.超敏原位可视化活性葡萄糖脑苷脂酶分子。
Nat Chem Biol. 2010 Dec;6(12):907-13. doi: 10.1038/nchembio.466. Epub 2010 Oct 31.
5
X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.N370S 突变型人酸性β-葡萄糖苷酶的 X 射线和生化分析。
J Biol Chem. 2011 Jan 7;286(1):299-308. doi: 10.1074/jbc.M110.150433. Epub 2010 Oct 27.
6
Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S.最常见的戈谢病突变体 N370S 中葡萄糖脑苷脂酶活性降低的分子基础。
J Biol Chem. 2010 Dec 31;285(53):42105-14. doi: 10.1074/jbc.M110.172098. Epub 2010 Oct 27.

本文引用的文献

1
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.与酸性β-葡萄糖苷酶结合的N-丁基-和N-壬基-脱氧野尻霉素复合物的晶体结构:对戈谢病中化学伴侣作用机制的见解。
J Biol Chem. 2007 Sep 28;282(39):29052-29058. doi: 10.1074/jbc.M705005200. Epub 2007 Jul 31.
2
Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.含药理伴侣分子的酸性β-葡萄糖苷酶结构为戈谢病研究提供了新视角。
Nat Chem Biol. 2007 Feb;3(2):101-7. doi: 10.1038/nchembio850. Epub 2006 Dec 24.
3
Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease.戈谢病中缺陷酶——酸性β-葡萄糖苷酶不同糖基化形式的结构比较
Acta Crystallogr D Biol Crystallogr. 2006 Dec;62(Pt 12):1458-65. doi: 10.1107/S0907444906038303. Epub 2006 Nov 23.
4
Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.变异酸性β-葡萄糖苷酶的分析:戈谢病突变的影响
J Biol Chem. 2006 Feb 17;281(7):4242-53. doi: 10.1074/jbc.M511110200. Epub 2005 Nov 17.
5
X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.人酸性β-葡萄糖苷酶与 conduritol-B-环氧化物共价结合的 X 射线结构。对戈谢病的启示。
J Biol Chem. 2005 Jun 24;280(25):23815-9. doi: 10.1074/jbc.M502799200. Epub 2005 Apr 6.
6
Paenibacillus sp. TS12 glucosylceramidase: kinetic studies of a novel sub-family of family 3 glycosidases and identification of the catalytic residues.芽孢杆菌属TS12葡萄糖神经酰胺酶:3型糖苷酶新亚家族的动力学研究及催化残基的鉴定
Biochem J. 2004 Feb 15;378(Pt 1):141-9. doi: 10.1042/BJ20031028.
7
METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.葡萄糖脑苷脂的代谢。II. 戈谢病中酶缺乏的证据。
Biochem Biophys Res Commun. 1965 Jan 18;18:221-5. doi: 10.1016/0006-291x(65)90743-6.
8
X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.戈谢病中缺陷酶——人酸性β-葡萄糖苷酶的X射线结构。
EMBO Rep. 2003 Jul;4(7):704-9. doi: 10.1038/sj.embor.embor873.
9
Gaucher's disease: identification of novel mutant alleles and genotype-phenotype relationships.戈谢病:新型突变等位基因的鉴定及基因型-表型关系
Clin Genet. 2003 Jul;64(1):57-64. doi: 10.1034/j.1399-0004.2003.00100.x.
10
Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells.人葡萄糖脑苷脂酶:活性位点突变体在小鼠空细胞中的异源表达
Glycobiology. 2000 Nov;10(11):1217-24. doi: 10.1093/glycob/10.11.1217.